Teva to Present at the Goldman Sachs 37th Annual Global Healthcare Conference
06 Juin 2016 - 2:00PM
Business Wire
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live
audio webcast at the Goldman Sachs 37th Annual Global Healthcare
Conference. Siggi Olafsson will present on Wednesday, June 8, 2016
at 8:40 AM PT.
What:
Teva Presentation at the Goldman Sachs 37th Annual Global
Healthcare Conference
Who:
Siggi Olafsson, President and CEO, Global Generic Medicines Teva
Pharmaceutical Industries Ltd.
When:
Wednesday, June 8, 2016
Where:
www.ir.tevapharm.com
How:
Live over the Internet – log on to the Web at the address above and
register for the event (approximately 10 minutes before). An
archive of the webcast will be available on Teva’s website.
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a
leading global pharmaceutical company that delivers high-quality,
patient-centric healthcare solutions used by millions of patients
every day. Headquartered in Israel, Teva is the world’s largest
generic medicines producer, leveraging its portfolio of more than
1,000 molecules to produce a wide range of generic products in
nearly every therapeutic area. In specialty medicines, Teva has a
world-leading position in innovative treatments for disorders of
the central nervous system, including pain, as well as a strong
portfolio of respiratory products. Teva integrates its generics and
specialty capabilities in its global research and development
division to create new ways of addressing unmet patient needs by
combining drug development capabilities with devices, services and
technologies. Teva's net revenues in 2015 amounted to $19.7
billion. For more information, visit www.tevapharm.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160606005212/en/
Teva Pharmaceutical Industries Ltd.IR Contacts:United
StatesKevin C. Mannix, 215-591-8912orUnited StatesRan
Meir, 215-591-3033orIsraelTomer Amitai, 972 (3)
926-7656orPR Contacts:IsraelIris Beck Codner, 972 (3)
926-7246orUnited StatesDenise Bradley, 215-591-8974
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024